Tag Archives: Brazil health regulator gives nod for Chinese COVID-19 vaccine trial

Brazilian health regulator Anvisa on Friday approved clinical trials of a potential coronavirus vaccine developed by China’s Sinovac, according to an official gazette publication. The study – first announced on June 11 – is led by Instituto Butantan, a research center funded by the state of Sao Paulo. The agreement with Sinovac includes not only trials but also the transference …

Read More »